Evaluation of natural killer cell (CD57) as a prognostic marker in oral squamous cell carcinoma: An immunohistochemistry study.

Rashmi Agarwal, Minal Chaudhary, Shruti Bohra, Shree Bajaj
Author Information
  1. Rashmi Agarwal: Department of Oral and Maxillofacial Pathology, Dr. B. R. Ambedkar Institute of Dental Sciences and Hospital, Patna, Bihar, India.
  2. Minal Chaudhary: Department of Oral and Maxillofacial Pathology and Microbiology, Sharad Pawar Dental College, Wardha, Maharashtra, India.
  3. Shruti Bohra: Department of Oral and Maxillofacial Pathology and Microbiology, Sharad Pawar Dental College, Wardha, Maharashtra, India.
  4. Shree Bajaj: Department of Oral and Maxillofacial Pathology and Microbiology, Sharad Pawar Dental College, Wardha, Maharashtra, India.

Abstract

OBJECTIVES: Natural killer (NK) cells are important effector lymphocytes. NK cells are considered to represent innate immune system. NK cells target and kill aberrant cells such as virally infected and tumorigenic cells. The purpose of this study was to assess the expression of CD57 in oral squamous cell carcinoma (OSCC) and to correlate the expression of CD57 with 3 years survival in patients with OSCC.
MATERIALS AND METHODS: About 100 histopathologically diagnosed cases of OSCC of various grades were divided into two groups, i.e., Group I (dead patients) and Group II (live patients) from the archives of Department of Oral Pathology and Microbiology. CD57 was detected in these tissues by immunohistochemistry.
RESULT: The results were analyzed using Spearman's correlation coefficient and students unpaired t-test. The mean CD57 labeling index in Group II was significantly higher than that found in Group I (P = 0.000). There was a significant correlation (P = 0.00) in the mean CD57 levels between Groups I and II and prognosis of patient.
CONCLUSION: CD57 could be a good prognostic marker for OSCC patients.

Keywords

References

  1. J Oral Sci. 2010 Jun;52(2):267-73 [PMID: 20587952]
  2. J Biomed Biotechnol. 2011;2011:203628 [PMID: 21629745]
  3. Chin Med J (Engl). 1995 Jul;108(7):516-21 [PMID: 7555270]
  4. Blood. 2010 Nov 11;116(19):3865-74 [PMID: 20733159]
  5. J Clin Invest. 2007 May;117(5):1175-83 [PMID: 17476347]
  6. J Oral Pathol Med. 2010 Feb;39(2):162-7 [PMID: 19754647]
  7. Nat Rev Immunol. 2012 Mar 22;12(4):239-52 [PMID: 22437937]
  8. Cancer. 1997 Jun 15;79(12):2320-8 [PMID: 9191519]
  9. J Innate Immun. 2011;3(3):216-26 [PMID: 21454962]
  10. Anticancer Res. 2012 May;32(5):2129-32 [PMID: 22593500]
  11. Asian Pac J Cancer Prev. 2012;13(2):715-8 [PMID: 22524849]
  12. Clin Cancer Res. 2000 Jul;6(7):2794-802 [PMID: 10914726]
  13. Lung Cancer. 2002 Jan;35(1):23-8 [PMID: 11750709]
  14. Curr Opin Genet Dev. 2005 Feb;15(1):97-101 [PMID: 15661539]
  15. Virchows Arch. 1998 May;432(5):427-32 [PMID: 9645441]
  16. Annu Rev Pathol. 2006;1:119-50 [PMID: 18039110]
  17. Cancer. 2000 Feb 1;88(3):577-83 [PMID: 10649250]
  18. N Engl J Med. 2003 Nov 27;349(22):2091-8 [PMID: 14645636]
  19. Immunology. 1995 Jun;85(2):338-46 [PMID: 7642226]
  20. Immunology. 2009 Sep;128(1):7-15 [PMID: 19689731]
  21. J Immunol. 2007 Apr 1;178(7):4011-6 [PMID: 17371953]
  22. Br J Cancer. 1999 Nov;81(5):881-9 [PMID: 10555762]
  23. Semin Oncol. 2002 Jun;29(3 Suppl 7):5-11 [PMID: 12068382]
  24. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4510-5 [PMID: 9539768]

Word Cloud

Created with Highcharts 10.0.0CD57cellscelloralOSCCpatientsGroupkillerNKsquamousIIstudyexpressioncarcinomaimmunohistochemistrycorrelationmeanP=0prognosticmarkernaturalOBJECTIVES:Naturalimportanteffectorlymphocytesconsideredrepresentinnateimmunesystemtargetkillaberrantvirallyinfectedtumorigenicpurposeassesscorrelate3yearssurvivalMATERIALSANDMETHODS:100histopathologicallydiagnosedcasesvariousgradesdividedtwogroupsiedeadlivearchivesDepartmentOralPathologyMicrobiologydetectedtissuesRESULT:resultsanalyzedusingSpearman'scoefficientstudentsunpairedt-testlabelingindexsignificantlyhigherfound000significant00levelsGroupsprognosispatientCONCLUSION:goodEvaluationcarcinoma:cancer

Similar Articles

Cited By